However, we find that even the TRX pathway is further compromised in NE SCLC through the upregulated expression of TXNIP pushing NE SCLC toward the “edge of the cliff” of anti-oxidant defense failure. The gene discussed is TXNIP; the disease is small cell lung carcinoma.